Navigating the New HSR Landscape: Major Updates and Enforcement Actions You Need to Know

By: Jay L. Levine (Porter Wright)
In this piece, author Jay L. Levine explores recent changes and updates to US competition law and their effects on antitrust enforcement, providing background on the shifting perception of the Hart-Scott-Rodino (HSR) Act among business executives and transactional lawyers. Once treated as a routine procedural step in mergers and acquisitions, HSR compliance is now under greater scrutiny due to recent enforcement actions and significant changes to the HSR filing process. The days of simply “checking the HSR box” are waning as regulators demand greater diligence and transparency.
Levine provides background on the HSR Act, which was enacted to give federal antitrust agencies an opportunity to review significant mergers and acquisitions before they are finalized. Under the Act, parties must file a Report and Notification Form and observe a 30-day waiting period before closing. If antitrust concerns arise, agencies may issue a “Second Request” to gather more information, extending the review period. The Act’s core requirement is that transactions cannot close until the waiting period has expired.
Recent enforcement actions underscore this point. In one case, the government penalized a buyer $5.6 million for “gun jumping”—unlawful pre-merger coordination such as managing the seller’s contracts and pricing decisions before the waiting period ended. In another case, the DOJ sued a private equity firm for allegedly submitting incomplete HSR filings across multiple deals, citing missing competitive analysis documents. The firm responded by filing its own lawsuit, arguing that the government was unfairly enforcing overly complex and inconsistent rules…
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas